Search for: "Andrews v. USA" Results 21 - 40 of 454
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Feb 2014, 12:22 pm by Gregory J. Brodzik
Judge Andrews found this inquiry to accord with the reasoning from Uniloc USA, Inc. v. [read post]
., Ltd. and HEC Pharm USA Inc., vacated its prior decision, and reversed the district court’s judgment that the claims of patent at issue were not invalid (Novartis Pharmaceuticals Corporation. v. [read post]
3 Aug 2011, 2:10 pm by Andrew Wooley
 By Andrew Wooley           The Supreme Court of Texas’ recent decision in Marsh USA Inc. v. [read post]
17 May 2009, 9:55 pm
By Andrew Williams -- Last Thursday, the Federal Circuit affirmed the decision of the District Court for the District of New Jersey denying a request by Altana Pharma and Wyeth (collectively "Altana") for a preliminary injunction to prevent Teva Pharmaceuticals ("Teva") from marketing a generic version of the antiulcer drug Protonix ®. [read post]
The only contentions of error the inventor made were issues of claim construction, which he forfeited by not raising them at the appropriate time during the inter partes review proceeding (Driessen v. [read post]
The board’s claim construction and motivation to combine analysis were supported by the record (Shamoon v. [read post]
9 Jun 2022, 4:03 am by Linda O'Brien (CCH)
Thus, the Board’s decision that the challenged claims of the patent were unpatentable was affirmed (Ethicon LLC v. [read post]
Justice Gorsuch, in a dissenting opinion joined by Justice Sotomayor, expressed strong disagreement with the majority’s interpretation of Section 315(b) as “another step down the road of ceding core judicial powers to agency officials and leaving the disposition of private rights and liberties to bureaucratic mercy” (Thryv, Inc. v. [read post]
27 Jun 2018, 1:50 pm by Jon Levitan
This morning the court issued a 5-4 opinion in Janus v. [read post]
Any error in the Board’s claim construction was harmless and substantial evidence, including the claim language and expert testimony, supported the Board’s findings of motivation to combine (Bot M8 LLC v. [read post]
5 Mar 2014, 5:52 am by Amy Howe
  Ronald Mann previewed the argument for this blog; other coverage and commentary come from Richard Wolf of USA Today, Chanakya Sethi at Slate, and Andrew Pincus at Mayer Brown’s Class Defense Blog. [read post]
28 Oct 2013, 7:23 am by Docket Navigator
Zydus Pharmaceuticals (USA) Inc. et. al., 1-11-cv-01105 (DED October 24, 2013, Order) (Andrews, J.) [read post]